(Total Views: 155)
Posted On: 04/01/2019 1:05:40 PM
Post# of 15407

$TROV News Article - Phase 1b/2 Dose Escalation Trial of Onvansertib in Relapsed/Refractory AML Demonstrates Safety, Tolerability and Relative Durability with Complete Responses at Highest Dose Levels https://marketwirenews.com/news-releases/phas...25332.html


My Twitter: WhyteStocks